|By Marketwired .||
|August 13, 2013 01:45 PM EDT||
NEW YORK, NY -- (Marketwired) -- 08/13/13 -- TriMarkPublications.com cites in its new report, "Bioseparation Systems for Global Biopharmaceutical Markets," that the global market for bioseparation systems for biopharmaceutical manufacturing will jump to $6 billion by 2018. While North America and Europe will continue to account for a significant share of revenue, the emerging countries of China, India, Brazil and Russia are rapidly increasing share, growing at a CAGR of 22%. For more information, visit: http://www.trimarkpublications.com/bioseparation-systems-for-global-biopharmaceutical-markets/.
The demand for single use products is increasing and fueling growth of the global bioseparation systems market. Blockbuster biologics are going off patent, leaving the market open for developing and manufacturing low cost biosimilars. The Asian countries of India, Singapore, South Korea and China are fast becoming biomanufacturing hubs, producing biosimilars for their own large populations and for Southeast Asia.
Bioseparation systems can be categorized into three types: chromatography, membranes/filters and centrifuges. In this report, each is examined in detail, including market size, drivers and restrictors, competitors and technology. In 2013, chromatography will contribute $1.8 billion to the global bioseparation systems market. Membranes/filters will contribute $1.4 billion, followed by centrifuges ($400 million).
The "Bioseparation Systems for Global Biopharmaceutical Markets" report covers:
- Single use products
- Manufacturing capacity
- Applications of bioseparation systems in downstream processing
- Downstream processing bottlenecks
- Emerging bioseparation system technologies
- Manufacturing capacity by biopharmaceutical company, CMO and region
The "Bioseparation Systems for Global Biopharmaceutical Markets" report examines companies manufacturing biopharmaceutical manufacturing equipment and supplies in the world. Companies covered include: Alfa Laval, Alfa Wasserman, Applied Biosystems (Life Technologies), Asahi Kasei, BAC B.V. (Life Technologies), Bio-Rad, Carr Centritech, Celeros, Dow Chemical Company, DSM Biologics, Flottweg, G-Con, GEA Westfalia, GE Healthcare Life Sciences, Hitachi Koki, Knauer, Kronlab Division YMC Europe, 3M Purification (CUNO), Merck Millipore, Novavax, Novasep, NuSep, Pall Corporation, PriME, ProMetric, Sartorius, SciLog, Spectrum, Tarpon, Tosoh and Waters.
Detailed charts with sales forecasts and marketshare data are included. For more information, visit: http://www.trimarkpublications.com/bioseparation-systems-for-global-biopharmaceutical-markets/.
TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit http://www.trimarkpublications.com.
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.